Comparison Chart Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
16:00:02 2026-08-20 EDT
|
5-day change | 1st Jan Change | ||
| 291.45 USD | +0.50% |
|
+3.62% | +46.10% |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Other Biotechnology & Medical Research | +0.50% | +3.62% | +46.10% | +82.64% | -31.38% | 13.91B |  | | |
Select your edition
All financial news and data tailored to specific country editions
